{"lastClose": 39.189998626708984, "len": 267, "date": "2023-01-31", "alpha_1": 1.9566830050855661, "beta_1": 1.031666725662842, "drawup_1": 4.9751826094910365, "sharpe_1": 1.1442111857015027, "natr_1": 5.559228672543408, "sup_1": -0.19966823618573867, "res_1": 0.1974994361665046, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 54.55442366271402, "adx_1": 11.984021152456515, "drawdown_1": -0.7917933256250944, "stratHoldSharpe_1": 0.9747105042231584, "stratHoldAlpha_1": 251.94934839737058, "stratHoldDrawdown_1": -0.7343084574133419, "alpha_3mo": 0.4351974257802418, "beta_3mo": 1.1561895254864956, "drawup_3mo": 0.24786589198847264, "sharpe_3mo": 1.1906861010978866, "natr_3mo": 5.559228672543408, "sup_3mo": -0.018797272664946445, "res_3mo": 0.04329339241004053, "bullPattern_3mo": ["SHORTLINE"], "bearPattern_3mo": [], "rsi_3mo": 60.47651355486907, "adx_3mo": 23.337272578694698, "drawdown_3mo": -0.15231787564688803, "stratHoldSharpe_3mo": 1.4671825606849165, "stratHoldAlpha_3mo": 251.66852919961673, "stratHoldDrawdown_3mo": -0.13899792844788228, "Industry": "Biotechnology: Pharmaceutical Preparations", "Country": "United States", "Sector": "Health Care", "Name": "Amylyx Pharmaceuticals Inc.", "Market Cap": 2587305313, "IPO Year": 2022.0, "alpha%_1": 0.999999999992921, "beta%_1": 0.5376606261932657, "drawup%_1": 1.0, "sharpe%_1": 0.6879162756438442, "natr%_1": 0.7679993487145497, "drawdown%_1": 0.02179918053130205, "stratHoldSharpe%_1": 0.8710647774991704, "stratHoldAlpha%_1": 0.9996864848096506, "stratHoldDrawdown%_1": 0.019283455648208582, "alpha%_3mo": 0.6100444081792538, "beta%_3mo": 0.6105221857742833, "drawup%_3mo": 0.47479176024258263, "sharpe%_3mo": 0.1714602865565515, "natr%_3mo": 0.7633571287337307, "drawdown%_3mo": 0.5030055842954575, "stratHoldSharpe%_3mo": 0.47333397259032656, "stratHoldAlpha%_3mo": 0.5948665925148269, "stratHoldDrawdown%_3mo": 0.5006315529104581}